"Prion-proof" for [PIN+]: Infection with In Vitro-made Amyloid Aggregates of Rnq1p-(132-405) Induces [PIN+]

Journal of Molecular Biology

Volumn 365, Issue 3, 2007, Pages 773-782

  Patel, Basant K ^a   Liebman, Susan W ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

amyloid like; prion; protein only; Rnq1p; PIN+

Indexed keywords

AMINO ACID; AMYLOID; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; POLYGLUTAMINE; PRION PROTEIN; PROTEINASE K; RECOMBINANT PROTEIN; RNQ1P PROTEIN;

ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; FUNGUS CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SCRAPIE; SPHEROPLAST; YEAST;

BOS TAURUS; MAMMALIAN PRION;

EID: 33845605514     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.10.069     Document Type: Article

References (52)

1. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 216 (1982) 136-144
2. Prusiner S.B. Prions. Proc. Natl Acad. Sci. USA 95 (1998) 13363-13383
3. Griffith J.S. Self-replication and scrapie. Nature 215 (1967) 1043-1044
4. Liebman S. Progress toward an ultimate proof of the prion hypothesis. Proc. Natl Acad. Sci. USA 99 (2002) 9098-9100
5. Wickner R.B. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264 (1994) 566-569
6. Sondheimer N., and Lindquist S. Rnq1: an epigenetic modifier of protein function in yeast. Mol. Cell 5 (2000) 163-172
7. Derkatch I.L., Bradley M.E., Hong J.Y., and Liebman S.W. Prions affect the appearance of other prions: the story of [PIN(+)]. Cell 106 (2001) 171-182
8. Coustou V., Deleu C., Saupe S., and Begueret J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc. Natl Acad. Sci. USA 94 (1997) 9773-9778
9. Maddelein M.L., Dos Reis S., Duvezin-Caubet S., Coulary-Salin B., and Saupe S.J. Amyloid aggregates of the HET-s prion protein are infectious. Proc. Natl Acad. Sci. USA 99 (2002) 7402-7407
10. King C.Y., and Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature 428 (2004) 319-323
11. Tanaka M., Chien P., Naber N., Cooke R., and Weissman J.S. Conformational variations in an infectious protein determine prion strain differences. Nature 428 (2004) 323-328
12. Brachmann A., Baxa U., and Wickner R.B. Prion generation in vitro: amyloid of Ure2p is infectious. EMBO J. 24 (2005) 3082-3092
13. King C.Y., Tittmann P., Gross H., Gebert R., Aebi M., and Wuthrich K. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc. Natl Acad. Sci. USA 94 (1997) 6618-6622
14. +], a heritable prion-like factor of S. cerevisiae. Cell 89 (1997) 811-819
15. Taylor K.L., Cheng N., Williams R.W., Steven A.C., and Wickner R.B. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 283 (1999) 1339-1343
16. Perutz M.F. Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem. Sci. 24 (1999) 58-63
17. Petkova A.T., Leapman R.D., Guo Z., Yau W.M., Mattson M.P., and Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307 (2005) 262-265
18. Legname G., Baskakov I.V., Nguyen H.O., Riesner D., Cohen F.E., DeArmond S.J., and Prusiner S.B. Synthetic mammalian prions. Science 305 (2004) 673-676
19. Silveira J.R., Raymond G.J., Hughson A.G., Race R.E., Sim V.L., Hayes S.F., and Caughey B. The most infectious prion protein particles. Nature 437 (2005) 257-261
20. Castilla J., Saa P., Hetz C., and Soto C. In vitro generation of infectious scrapie prions. Cell 121 (2005) 195-206
21. Derkatch I.L., Bradley M.E., Zhou P., Chernoff Y.O., and Liebman S.W. Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae. Genetics 147 (1997) 507-519
22. Meriin A.B., Zhang X., He X., Newnam G.P., Chernoff Y.O., and Sherman M.Y. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J. Cell Biol. 157 (2002) 997-1004
23. Derkatch I.L., Uptain S.M., Outeiro T.F., Krishnan R., Lindquist S.L., and Liebman S.W. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proc. Natl Acad. Sci. USA 101 (2004) 12934-12939
24. Collinge J., Sidle K.C., Meads J., Ironside J., and Hill A.F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383 (1996) 685-690
25. Bruce M.E. TSE strain variation. Br. Med. Bull. 66 (2003) 99-108
26. Derkatch I.L., Chernoff Y.O., Kushnirov V.V., Inge-Vechtomov S.G., and Liebman S.W. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 144 (1996) 1375-1386
27. Zhou P., Derkatch I.L., Uptain S.M., Patino M.M., Lindquist S., and Liebman S.W. The yeast non-Mendelian factor [ETA+] is a variant of [PSI+], a prion-like form of release factor eRF3. EMBO J. 18 (1999) 1182-1191
28. King C.Y. Supporting the structural basis of prion strains: induction and identification of [PSI] variants. J. Mol. Biol. 307 (2001) 1247-1260
29. Schlumpberger M., Prusiner S.B., and Herskowitz I. Induction of distinct [URE3] yeast prion strains. Mol. Cell Biol. 21 (2001) 7035-7046
30. Bradley M.E., Edskes H.K., Hong J.Y., Wickner R.B., and Liebman S.W. Interactions among prions and prion "strains" in yeast. Proc. Natl Acad. Sci. USA 99 (2002) 16392-16399
31. Ter-Avanesyan M.D., Dagkesamanskaya A.R., Kushnirov V.V., and Smirnov V.N. The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 137 (1994) 671-676
32. Liu J.J., Sondheimer N., and Lindquist S.L. Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+]. Proc. Natl Acad. Sci. USA 99 (2002) 16446-16453
33. Bradley M.E., and Liebman S.W. The Sup35 domains required for maintenance of weak, strong or undifferentiated yeast [PSI+] prions. Mol. Microbiol. 51 (2004) 1649-1659
34. Ter-Avanesyan M.D., Kushnirov V.V., Dagkesamanskaya A.R., Didichenko S.A., Chernoff Y.O., Inge-Vechtomov S.G., and Smirnov V.N. Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol. Microbiol. 7 (1993) 683-692
35. Bagriantsev S., and Liebman S.W. Specificity of prion assembly in vivo. [PSI+] and [PIN+] form separate structures in yeast. J. Biol. Chem. 279 (2004) 51042-51048
36. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
37. Collins S.R., Douglass A., Vale R.D., and Weissman J.S. Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLOS Biol. 2 (2004) e321
38. Perutz M.F., Johnson T., Suzuki M., and Finch J.T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl Acad. Sci. USA 91 (1994) 5355-5358
39. Conway K.A., Harper J.D., and Lansbury P.T. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39 (2000) 2552-2563
40. Krishnan R., and Lindquist S.L. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 435 (2005) 765-772
41. Kushnirov V.V., Kochneva-Pervukhova N.V., Chechenova M.B., Frolova N.S., and Ter-Avanesyan M.D. Prion properties of the Sup35 protein of yeast Pichia methanolica. EMBO J. 19 (2000) 324-331
42. Kryndushkin D.S., Alexandrov I.M., Ter-Avanesyan M.D., and Kushnirov V.V. Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J. Biol. Chem. 278 (2003) 49636-49643
43. Ripaud L., Maillet L., Immel-Torterotot F., Durand F., and Cullin C. The [URE3] yeast prion results from protein aggregates that differ from amyloid filaments formed in vitro. J. Biol. Chem. 279 (2004) 50962-50968
44. Hall D., Hirota N., and Dobson C.M. A toy model for predicting the rate of amyloid formation from unfolded protein. J. Mol. Biol. 351 (2005) 195-205
45. Atha D.H., and Ingham K.C. Mechanism of precipitation of proteins by polyethylene glycols. Analysis in terms of excluded volume. J. Biol. Chem. 256 (1981) 12108-12117
46. Ross E.D., Minton A., and Wickner R.B. Prion domains: sequences, structures and interactions. Nature Cell Biol. 7 (2005) 1039-1044
47. Sherman F., Fink G.R., and Hicks J.B. Methods in Yeast Genetics (1986), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
48. Schluter A., Wiesgigl M., Hoyer C., Fleischer S., Klaholz L., Schmetz C., and Clos J. Expression and subcellular localization of cpn60 protein family members in Leishmania donovani. Biochim. Biophys. Acta 1491 (2000) 65-74
49. Chernoff Y.O., Uptain S.M., and Lindquist S.L. Analysis of prion factors in yeast. Methods Enzymol. 351 (2002) 499-538
50. Tuite M.F., Mundy C.R., and Cox B.S. Agents that cause a high frequency of genetic change from [psi+] to [psi-] in Saccharomyces cerevisiae. Genetics 98 (1981) 691-711
51. Bradley M.E., Bagriantsev S., Vishveshwara N., and Liebman S.W. Guanidine reduces stop codon read-through caused by missense mutations in SUP35 or SUP45. Yeast 20 (2003) 625-632
52. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685